OnabotulinumtoxinA (Botox) appears to increase the activity of brain regions involved in sensation and processing of urinary urgency in female patients with neurogenic overactive bladder, says Rose Khavari, MD.
Among 321 scheduled telemedicine visits for patients with neurogenic bladder, the compliance rate was 91%.
Start saving and investing early in order to achieve your financial goals.
"EPCS is now live in all states, available through most EHR vendors, and probably cost effective in your practice," writes Robert A. Dowling, MD.
Apalutamide (Erleada) treatment in men with nonmetastatic castrate-resistant prostate cancer significantly improves metastasis-free survival and does so without adversely affecting health-related quality of life.
“A multivariable analysis confirmed that AR-V7 status independently predicted PSA response,” says researcher Matthias Heck, MD.
"Although we commend the USPSTF for upgrading the recommendation for PSA- and digital rectal exam-based prostate cancer screening from a “D” to a “C” grade (JAMA 2018; 319:1901–13), we believe that not enough emphasis is placed on screening high-risk groups for prostate cancer," write Navin Shah, MD, and Vladimir Ioffe, MD.
The final recommendation on screening for prostate cancer issued May 8 by the U.S. Preventive Services Task Force, which gives a “C” grade for PSA testing in men 55-70 years of age, has been met with mixed reviews by prostate cancer-focused organizations, some of which continue to call for legislation to reform the task force itself.
Findings from a retrospective analysis of data collected at the National Institutes of Health provide insight on how multiparametric MRI/transrectal ultrasound-fusion biopsy (“fusion biopsy”) may be affecting management patterns and outcomes for men with prostate cancer.
Urology visits afford a unique opportunity to discuss falls, drug use, and work accidents.